P-Cure/LinkedIn
Mar 8, 2025, 17:41
Retinoblastoma: Precision is Paramount – P-Cure
P-Cure shared a post on LinkedIn:
“Retinoblastoma, a rare eye cancer in children, often requires highly precise radiation treatment to preserve vision. One year ago, P-Cure successfully treated a four-year-old child with this condition.
For the first time, a child with ocular cancer was treated using a proton therapy system designed for patients of all ages, capable of targeting tumors regardless of their location, all while the patient remained seated.
This case highlights the critical importance of the precise execution of proton therapy in a comfortable, ergonomic position.
Want to learn more about P-Cure?
Contact us at: [email protected].”
More posts featuring P-Cure.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023